These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21494091)

  • 1. Intellectual property protection: strategies for antibody inventions.
    Storz U
    MAbs; 2011; 3(3):310-7. PubMed ID: 21494091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Obvious to try": a proper patentability standard in the pharmaceutical arts?
    Trask AV
    Fordham Law Rev; 2008 Apr; 76(5):2625-68. PubMed ID: 18546581
    [No Abstract]   [Full Text] [Related]  

  • 3. International intellectual property strategies for therapeutic antibodies.
    Storz U
    MAbs; 2011; 3(6):596-606. PubMed ID: 22123063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encouraging further innovation: Ariad v. Eli Lilly and the written description requirement.
    Jakas J
    Seton Hall Law Rev; 2012; 42(3):1287-36. PubMed ID: 22803220
    [No Abstract]   [Full Text] [Related]  

  • 5. Science and the law. Working through the patent problem.
    Walsh JP; Cohen WM; Arora A
    Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928
    [No Abstract]   [Full Text] [Related]  

  • 6. Patent law protection of inventions in medicine and pharmaceutical industry.
    Miladinović Z; Varga S; Radojković M
    Vojnosanit Pregl; 2013 Jun; 70(6):600-5. PubMed ID: 23885528
    [No Abstract]   [Full Text] [Related]  

  • 7. [Specificities of patent protection in the pharmaceutical industry: modalities and traits of intellectual property].
    Jannuzzi AH; Vasconcellos AG; de Souza CG
    Cad Saude Publica; 2008 Jun; 24(6):1205-18. PubMed ID: 18545747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Overview on Indian Patents on Biotechnology.
    Mallick A; Chandra Santra S; Samal AC
    Recent Pat Biotechnol; 2015; 9(3):198-213. PubMed ID: 27012291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research on the pharmaceutical intellectual property protection and supervision of pharmacy administration.
    Xu Z; Chen W
    Pak J Pharm Sci; 2017 May; 30(3(Special)):1081-1087. PubMed ID: 28671085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pfizer-Pharmacia: the smart fit for the future.
    Wiggins WP
    Expert Opin Investig Drugs; 2003 Jan; 12(1):1-3. PubMed ID: 12517249
    [No Abstract]   [Full Text] [Related]  

  • 11. Patent portfolios for biotech inventions.
    Wang SJ
    Nat Biotechnol; 2013 Jun; 31(6):501-3. PubMed ID: 23752433
    [No Abstract]   [Full Text] [Related]  

  • 12. Sources of innovation: an assessment of intellectual property.
    Kinch MS; Raffo J
    Drug Discov Today; 2015 May; 20(5):500-4. PubMed ID: 25499663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Strategy and core technologies for the secondary development of Chinese patent medicine].
    Zhagn BL; Fan XH; Liu Y; Qu HB; Zhang JH; Chegn YY
    Zhongguo Zhong Yao Za Zhi; 2013 Nov; 38(22):3797-800. PubMed ID: 24558853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectively managing an IP portfolio? Not an easy task.
    Pontremoli G
    Pharm Pat Anal; 2020 Jan; 9(1):7-8. PubMed ID: 32008443
    [No Abstract]   [Full Text] [Related]  

  • 15. Are the economics of pharmaceutical research and development changing?: productivity, patents and political pressures.
    Grabowski H
    Pharmacoeconomics; 2004; 22(2 Suppl 2):15-24. PubMed ID: 15660474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patent prosecution strategies for biotechnological inventions.
    Yeh JJ; Fernandez D
    Assay Drug Dev Technol; 2004 Dec; 2(6):697-702. PubMed ID: 15674028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Getting the most out of your IP--patent management along its life cycle.
    Bader MA; Gassmann O; Ziegler N; Ruether F
    Drug Discov Today; 2012 Apr; 17(7-8):281-4. PubMed ID: 22079191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patent quality.
    Sklan A
    Pharm Pat Anal; 2014 Jan; 3(1):17-24. PubMed ID: 24354975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enforcing pharmaceutical and biotech patent rights in China.
    Zhang YP; Deng MM
    Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760
    [No Abstract]   [Full Text] [Related]  

  • 20. China tightens IP protection, but concerns linger.
    Jia H
    Nat Biotechnol; 2009 Sep; 27(9):787-8. PubMed ID: 19741619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.